Thomas Jensen insider trades

Open-market stock purchases and sales by Thomas Jensen, CEO at Allarity Therapeutics, Inc, from SEC Form 4 filings since Jan 22, 2025.

Recent trades

DateStockTradeValue
Jan 28, 2026ALLR Allarity Therapeutics, IncBought (not open market)—

Companies traded

  • ALLR Allarity Therapeutics, Inc: other filings, last Jan 28, 2026

Get free alerts when Thomas Jensen files a new trade →